Diletta and OTAWA Health have been partners since April 2019. According to the CEO of Diletta Solutions and former Computer Science student at Unicamp, Michel Cusnir, the startup had bold plans to generate applications for new applications in the healthcare market and the partnership with Diletta would accelerate business with cutting-edge technical support.
The startup is a management platform for hospitals, clinics and medical teams and was recently selected in the technological challenge of IdeiaGov, the Innovation Hub of the Government of São Paulo. The Challenge aims to support the development of technological and innovative solutions to assist in the diagnosis of Covid-19 through images from Computed Tomography and chest X-rays.
The solution presented by the startup is aimed at screening patients with Covid-19 symptoms, combining the use of a mobile application and cloud servers to analyze images. By configuring x-ray equipment to send x-rays directly to applications, the doctor quickly receives an answer about the percentage probability of diagnosing the disease, speeding up care and reducing costs and unnecessary hospitalizations.
According to Cusnir, the choice to work with x-rays in relation to computed tomography is related to the startup's objective of developing cutting-edge healthcare solutions for patients with lower purchasing power. This is because the technology is cheaper, promotes faster diagnoses and is available in emerging countries and rural and remote areas. Aiming to expand the use of the solution, it was developed in Portuguese, Spanish and English.
At the moment, the application is being tested and the selection on IdeiaGov will support us in closing partnerships: “We believe that the selection on IdeiaGov will help us to establish partnerships, as it validates the seriousness of the work that was done and the potential of the solution”, commented Cusnir. In addition to negotiations taking place with the public sector such as the Institute of Radiology of the Hospital das Clínicas of the Faculty of Medicine of the University of São Paulo (INRAD- HCFMUSP) and manufacturers of x-ray equipment, OTAWA also expects to carry out negotiations with investors interested in accelerating the implementation of the solution.
History
Diletta Solutions was born with innovation in its DNA. Spin-off of a leader in software development for the telecommunications area, the company grew and established itself with support from Unicamp: It was incubated in the Unicamp Technological Base Incubator (Incamp) and is currently installed in the University's Scientific and Technological Park . The startup provides technological solutions for companies, is a partner in eight other startups and recently launched its first product on the market: a digital payments platform.
CEO Michel Cusnir says that, originally, the company was designed to act as an external software development department for other companies, but that his contact and experience in creating and monitoring startups led the company to have an innovative business model: being a partner in other startups, working both in technological management and in structuring the business model.
Diletta currently serves 14 startups and is a partner in eight of them. The portfolio includes national and foreign clients, including Ifood, the leader in food deliveries in Latin America. According to Cusnir, the startup provides cutting-edge technical support for all customers and, for startups with which it has partnerships, it offers a service for analyzing economic viability and structuring the business model. The entrepreneur explains that the decision-making process regarding society in client startups is the responsibility of the company's board, which evaluates the business model, the entrepreneurs and the startup's market.
Among the companies that recently arrived in the portfolio is a Brazilian e-Health startup, OTAWA Health, which has global reach and recently received a maximum investment (series A) from Venture Capital. As a partner, Diletta assists OTAWA Health in developing a global platform that will have capabilities for monitoring, predicting and improving results in cancer treatment, in addition to being low-cost.
Matter originally published on the Unicamp Innovation Agency website.
